Are the benefits of breast milk stimulant worth the risk?
2014-12-04
(Press-News.org) Los Angeles, CA (Nov 4, 2014) Most women can make all the milk their baby needs, but some mothers turn to medications to help increase their supply. While some specialists encourage the off-label use of domperidone to stimulate breast milk production, some studies have suggested it may be related to negative side effects, including irregular heartbeat and sudden cardiac death. In a new article out today, researchers concluded that although domperidone can increase breast milk production, and there is no known risk to the babies who drink the milk, risks to women are still worrying. This review article was published today in Journal of Human Lactation, a SAGE journal.
In order to assess the efficiency and safety of domperidone, researchers Catherine Paul et al. analyzed both the limited studies available on maternal and infant exposure to the stimulant as well as larger studies focused on its use in gastrointestinal disorder treatment. The researchers found the following for those exposed to the drug:
No adverse effects were observed in a limited sample of 85 infants and 60 treated mothers
Breast milk production moderately improved after 3 daily dosages of 10-20 mg; however some institutions suggest doses as high as 120 or 160 mg.
It increased the odds ratio for sudden cardiac death inpatients using more than 30 mg daily
As some women are highly susceptible to certain heart diseases, the researchers claimed the use of domperidone was especially worrisome: "In these circumstances, an improvement of breastfeeding practices seems to be more effective and safer than the use of an off-label domperidone treatment."
INFORMATION:
Find out more by reading the article, "Use of Domperidone as a Galactagogue Drug: A Systematic Review of the Benefit-Risk Ratio," in the Journal of Human Lactation. For an embargoed copy of the article, please email camille.gamboa@sagepub.com.
Journal of Human Lactation (JHL) is a quarterly, peer-reviewed journal publishing original research, commentaries relating to human lactation and breastfeeding behavior, case reports relevant to the practicing lactation consultant and other health professionals who assist lactating mothers or their breastfeeding infants, debate on research methods for breastfeeding and lactation studies, and discussions of the business aspects of lactation consulting. http://jhl.sagepub.com/
Impact Factor: 1.638 | Ranking:12/106 in Nursing | 41/77 in Obstetrics & Gynecology | 49/121 in Pediatrics
Source: 2012 Journal Citation Reports® (Thomson Reuters, 2013)
SAGE is a leading international publisher of journals, books, and digital media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC.
http://www.sagepublications.com
ELSE PRESS RELEASES FROM THIS DATE:
2014-12-04
Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called ...
2014-12-04
PULLMAN, Wash.--Washington State University researchers have detailed the role of localized climate change in one of the great mysteries of North American archaeology: the depopulation of southwest Colorado by ancestral Pueblo people in the late 1200s.
In the process, they address one of the mysteries of modern-day climate change: How will humans react?
Writing in Nature Communications, WSU archaeologist Tim Kohler and post-doctoral researcher Kyle Bocinsky use tree-ring data, the growth requirements of traditional maize crops and a suite of computer programs to make ...
2014-12-04
This news release is available in French. A new technology that reveals cellular gene transcription in greater detail has been developed by Dr. Daniel Kaufmann of the University of Montreal Hospital Research Centre (CRCHUM) and the research team he directed. "This new research tool offers us a more profound view of the immune responses that are involved in a range of diseases, such as HIV infection. At the level of gene transcription, this had been difficult, complex and costly to do with current technologies, such as microscopy," explained the University of Montreal ...
2014-12-04
The first scientific evidence of frankincense being used in Roman burial rites in Britain has been uncovered by a team of archaeological scientists led by the University of Bradford. The findings - published today in the Journal of Archaeological Science - prove that, even while the Roman Empire was in decline, these precious substances were being transported to its furthest northern outpost.
The discovery was made by carrying out molecular analysis of materials previously thought to be of little interest - debris inside burial containers and residues on skeletal remains ...
2014-12-04
Vienna, Austria - 04 December 2014: Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEcho-Imaging 2014 by Dr Hilal Erken Pamukcu, cardiologist at Ankara Diskapi Education and Research Hospital in Turkey.
EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), a registered branch of the European Society of Cardiology (ESC), and is held 3-6 December in Vienna, Austria.
Dr Erken Pamukcu said: "Parkinson's disease is a neurological ...
2014-12-04
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication. A study finds that almost 40 percent of people with first-episode psychosis in community mental health clinics across the country might benefit from medication treatment changes.
Psychosis is a mental disorder in which thoughts and emotions ...
2014-12-04
It has been a long held belief that tumors arising from exposure to asbestos are caused by mutations in one cell, which then produces multiple clones. This hypothesis is challenged by new research published in the open access Journal of Translational Medicine, which suggests it is caused by mutations in multiple cells.
Malignant mesothelioma is a rare form of cancer that affects the mesothelium - the protective lining that covers the internal organs, such as the lungs, the heart and the abdominal cavity. It is estimated that malignant mesothelioma affects up to 3,200 ...
2014-12-04
Some previous studies have linked the diabetes medication pioglitazone to bladder cancer. However a new study − including more than one million people in six populations worldwide − has found no link between either pioglitazone or rosiglitazone (also known as Avandia) and bladder cancer. The new study is published in Diabetologia (the journal of the European Association for the Study of Diabetes), and is by Dr Samira Bell, Professor Helen Colhoun and Mr Danny Levin, University of Dundee, UK, and colleagues from the International Diabetes and Cancer Research ...
2014-12-04
Children born prematurely are at an increased risk of flu-related complications, despite not being identified as an "at risk" group in UK, USA, or WHO guidelines, and should be a priority group for the seasonal flu vaccination, new research published in The Lancet Respiratory Medicine suggests.
"Until now, guidelines highlighting groups at greater risk of developing complications from influenza, such as pneumonia, have been based on consensus opinion rather than on systematic assessment of the evidence"*, explains Dr Kay Wang from the University of Oxford in the UK. ...
2014-12-04
Researchers at the National Institutes of Health have found a duplication of a short stretch of the X chromosome in some people with a rare disorder that causes excessive childhood growth. They believe that a single gene within the region likely has a large influence on how much children grow. The research comes from a lab at NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which seeks to understand growth.
"Finding the gene responsible for childhood overgrowth would be very helpful, but the much wider question is what ...
LAST 30 PRESS RELEASES:
[Press-News.org] Are the benefits of breast milk stimulant worth the risk?
